Volume 27, Issue 3 - Editing
The vast majority of investigator brochures lack sufficient information to systematically appraise the strength of the supporting pre clinical findings
Download Full Article
You must be a member of EMWA in order to download the full article.
EMWA members please log in to download the full article.
If you would like to become a member of EMWA, please join here.
Wieschowski S, Chin WWL, Federico C, Sievers S, Kimmelman J, Strech D. Preclinical efficacy studies in investigator brochures: Do they enable risk-benefit assessment? PLoS Biology. 2018; 16(4):e2004879.
Cohen D. Oxford TB vaccine study calls into question selective use of animal data. BMJ. 2018; 360:j5845.
Wiersma M, Kerridge I, Lipworth W, Rodwin M. Should we try to manage nonfinancial interests? BMJ. 2018;361:k1240.
Outside interests. Nature research journals will ask authors to declare non-financial conflicts. Nature. 2018;554:6.
Winchester C. Give every paper a read for reproducibility. Nature. 2018;557:281.
Gunsalus CK, Robinson AD. Nine pitfalls of research misconduct. Nature. 2018;557:297-9.
Moher D, Naudet F, Cristea IA, Miedema F, Ioannidis JPA, Goodman SN. Assessing scientists for hiring, promotion, and tenure. PLoS Biol. 2018;16(3):e2004089.